CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2020; 29(01): 039-042
DOI: 10.1055/s-0039-1688464
Original Article | Artículo Original
Urologic Oncology/Urología Oncológica
Sociedad Colombiana de Urología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Microlitiasis testicular como factor de riesgo de Cáncer testicular - Estudio de casos y controles

Testicular Microlithiasis: A Risk Factor for Testicular Cancer – A Case Control Study
Hugo López-Ramos
1   Departamento de Urología. Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Mauricio Medina-Rico
2   Departamento de Epidemiología Clínica y Bioestadística. Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Sofía Manjarrés
3   Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Maria Camila Usubillaga
4   Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Daniela Sierra
5   Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

18. Dezember 2018

19. März 2019

Publikationsdatum:
27. Juni 2019 (online)

Resumen

Introducción Con una prevalencia entre el 1,5% y el 5,6%, la microlitiasis testicular es un hallazgo incidental. Aunque se ha propuesto una posible asociación entre la microlitiasis testicular y el cáncer testicular dicha relación no ha sido comprobada.

Objetivos Establecer la relación entre microlitiasis testicular y cáncer testicular.

Métodos Se realizó un estudio de casos y controles con la base de datos de un hospital de la ciudad de Bogotá de pacientes atendidos entre 2007 y 2017. Tanto casos como controles debían tener entre 5 y 35 años de edad, sin otros antecedentes que aumentaran el riesgo de cáncer testicular (criptorquidia, antecedente de cáncer testicular contralateral). Los casos debían tener reporte ecográfico y patológico del cáncer testicular así como una historia clínica completa de valoración por Urología. Los controles fueron pacientes que consultaron por otros cuadros de molestia testicular a quienes se les descartó ecográficamente la presencia de cáncer.

Resultados Se identificaron 24 casos y 96 controles. Al momento de calcular los riesgos relativos indirectos, se obtuvieron un OR crudo de 7,86 (95% CI 2,3 - 26,86) y un OR ajustado por tabaquismo de 10,66 (95% IC 3,29 - 34,55). Al ajustar por edad, historia de cáncer familiar y antecedente de varicocele, no se encontraron diferencias.

Conclusión Existe una aparente asociación entre microlitiasis testicular y cáncer testicular. A pesar de eso, estudios con tamaños de muestra más grande serían beneficiosos. Así mismo, al no poder determinar la existencia de una asociación temporal que permita hablar de causalidad entre las dos condiciones, esos resultados deben tomarse con cautela.

Abstract

Introduction Testicular microliathiasis is an incidental finding with a prevalence that varies between 1,5% and 5,6%. Although a possible association between testicular microlithiasis and testicular cancer has been proposed, this relationship has not been proven.

Objective To establish the association between testicular microlithiasis and testis cancer.

Methods A case-control study was conducted with the database of a hospital in the city of Bogotà, Colombia, of patients treated between 2007 and 2017. Both cases and controls should be between 5 and 35 years of age, with no other history that would increase the risk of testicular cancer (cryptorchidism, antecedent of contralateral testicular cancer). The cases had to have an ecographic and pathological report of testicular cancer as well as a complete clinical history of assessment by Urology. Likewise, the control group were patients who attended during the same period, with other testicular problems, such as: hydrocele, varicocele or inguinal hernia and with ultrasound findings that ruled out testicular cancer.

Results We identified 24 cases and 96 controls. We found a crude OR of 7.86 (95% CI 2.3–26.86) and an OR adjusted for smoking of 10.66 (95% CI 3.29–34, 55). When adjusting for age, family cancer history and varicocele history, no differences were found.

Conclusion There is an apparent association between testicular microlithiasis and testicular cancer. Despite this, studies with larger sample sizes would be beneficial. Likewise, since it cannot determine the existence of a temporary association that allows to speak of causality between the two conditions, these results must be taken with caution.

 
  • Referencias

  • 1 Medina-Rico M, López-Ramos H. Testicular cancer epidemiology in developing countries. Review of the literature. Arch Esp Urol 2017; 70 (05) 513-523
  • 2 Baird DC, Meyers GJ, Hu JS. Testicular Cancer: Diagnosis and Treatment. Am Fam Physician 2018; 97 (04) 261-268
  • 3 Stevenson SM, Lowrance WT. Epidemiology and Diagnosis of Testis Cancer. Urol Clin North Am 2015; 42 (03) 269-275
  • 4 Albers P, Albrecht W, Algaba F. , et al; European Association of Urology. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60 (02) 304-319
  • 5 Correa Ochoa JJ, Velásquez Ossa D, Lopera Toro AR, Martínez González CH, Yepes Pérez A. Guía colombiana de cáncer de testículo. Urol Colomb. 2016; 25 (03) 274-285
  • 6 Shanmugasundaram R, Singh JC, Kekre NS. Testicular microlithiasis: Is there an agreed protocol?. Indian J Urol 2007; 23 (03) 234-239
  • 7 Meissner A, Mamoulakis C, de la Rosette JJ, Pes MPL. Clinical update on testicular microlithiasis. Curr Opin Urol 2009; 19 (06) 615-618
  • 8 Tan M-H, Eng C. Testicular microlithiasis: recent advances in understanding and management. Nat Rev Urol 2011; 8 (03) 153-163
  • 9 van Casteren NJ, Looijenga LHJ, Dohle GR. Testicular microlithiasis and carcinoma in situ overview and proposed clinical guideline. Int J Androl 2009; 32 (04) 279-287
  • 10 Serter S, Gümüş B, Unlü M. , et al. Prevalence of testicular microlithiasis in an asymptomatic population. Scand J Urol Nephrol 2006; 40 (03) 212-214
  • 11 Goede J, Hack WWM, van der Voort-Doedens LM, Sijstermans K, Pierik FH. Prevalence of testicular microlithiasis in asymptomatic males 0 to 19 years old. J Urol 2009; 182 (04) 1516-1520
  • 12 Derogee M, Bevers RF, Prins HJ, Jonges TG, Elbers FH, Boon TA. Testicular microlithiasis, a premalignant condition: prevalence, histopathologic findings, and relation to testicular tumor. Urology 2001; 57 (06) 1133-1137
  • 13 Sanli O, Kadioglu A, Atar M, Acar O, Nane I, Kadioglu A. Grading of Classical Testicular Microlithiasis Has No Effect on the Prevalence of Associated Testicular Tumors. 2008; 80 (03) 310-316
  • 14 Pedersen MR, Rafaelsen SR, Møller H, Vedsted P, Osther PJ. Testicular microlithiasis and testicular cancer: review of the literature. Int Urol Nephrol 2016; 48 (07) 1079-1086
  • 15 Wang T, Liu L, Luo J, Liu T, Wei A. A Meta-Analysis of the Relationship between Testicular Microlithiasis and Incidence of Testicular Cancer. Urol J 2015; 12 (02) 2057-2064
  • 16 Trout AT, Chow J, McNamara ER. , et al. Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population. Radiology 2017; 285 (02) 576-583
  • 17 Suominen JS, Jawaid WB, Losty PD. Testicular microlithiasis and associated testicular malignancies in childhood: a systematic review. Pediatr Blood Cancer 2015; 62 (03) 385-388
  • 18 Srivastava A, Kreiger N. Cigarette smoking and testicular cancer. Cancer Epidemiol Biomarkers Prev 2004; 13 (01) 49-54
  • 19 Kratz CP, Han SS, Rosenberg PS. , et al. Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 2011; 48 (07) 473-476
  • 20 Landero-Huerta DA, Vigueras-Villasenor RM, Yokoyama-Rebollar E. , et al. Epigenetic and risk factors of testicular germ cell tumors: a brief review. Front Biosci 2017; 22: 1073-1098
  • 21 Zhang L, Yu H, Hemminki O, Försti A, Sundquist K, Hemminki K. Familial Associations in Testicular Cancer with Other Cancers. Sci Rep 2018; 8 (01) 10880
  • 22 Patel KV, Navaratne S, Bartlett E. , et al. Testicular Microlithiasis: Is Sonographic Surveillance Necessary? Single Centre 14 Year Experience in 442 Patients with Testicular Microlithiasis. Ultraschall Med 2016; 37 (01) 68-73
  • 23 Marte A, Pintozzi L, Cretì G. , et al. Long-Term Follow-Up of Testicular Microlithiasis in Children and Adolescents: Multicenter Prospective Cohort Study of the Italian Society of Pediatric Urology. Eur J Pediatr Surg 2017; 27 (02) 155-160
  • 24 Yesil S, Tanyildiz HG, Sahin G. How should we monitor boys with testicular microlithiasis?. Pediatr Hematol Oncol 2016; 33 (03) 171-177
  • 25 Kola B. Pediatric Testicular Microlithiasis: To Refer or Not to Refer? Glob Pediatr Heal. 2017 ;4:2333794 × 17731854.
  • 26 Price NR, Charlton A, Simango I, Smith GHH. Testicular microlithiasis: the importance of self-examination. J Paediatr Child Health 2014; 50 (10) E102-E105